03.05.2010 • News

Lyondell Chemical Emerges from Bankruptcy

Lyondell Chemical  said on Friday that it has exited bankruptcy after a 16-month process during which its debt load was reduced to about $5 billion from $24 billion.

The company, which went bankrupt last January after a drop in business due to the economic downturn left it unable to make debt payments, was able to make the move through financial backing from two private equity firms and industrial holding company Access Industries.

Access, owned by financier Len Blavatnik, had taken Lyondell private in 2007. He has bought back into the new company through a $2.8 billion rights offering and will own a small stake alongside Apollo Management and Ares Management.

Lyondell also said it raised $3.25 billion of first priority debt. The new company, LyondellBasell Industries NV based in the Netherlands, said it expects to begin trading on the New York Stock Exchange by the third quarter of this year. LyondellBasell said it has $5.2 billion in net consolidated debt and about $3 billion in liquid assets.

The move comes after the company fended off a takeover attempt by India's Reliance Industries earlier this year. It also settled hundreds of environmental claims.

Company contact







From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.